What is the next step in management for a patient with markedly elevated aldosterone, an aldosterone‑to‑renin ratio of 203, hyponatremia, previously hypokalemia now corrected with potassium supplements, and normal ACTH and cortisol levels?

Proceed with Confirmatory Testing for Primary Aldosteronism

With an aldosterone-to-renin ratio of 203 (far exceeding the diagnostic threshold of 30-140 depending on units), elevated aldosterone of 67, and previously documented hypokalemia, you should proceed directly to confirmatory testing with either intravenous saline suppression test or oral salt loading test to definitively diagnose primary aldosteronism before initiating further workup. 1

Diagnostic Algorithm

Current Status Assessment

Your patient has a strongly positive screening test for primary aldosteronism:

• ARR of 203 is markedly elevated (cutoff is typically 30-140 depending on units used)
• Aldosterone level of 67 ng/dL is well above the minimum threshold of 10 ng/dL needed to interpret the ARR as positive 1
• Previous hypokalemia (now corrected with supplements) supports the diagnosis
• Normal ACTH (8.1) and cortisol (8.4) effectively rule out Cushing's syndrome or other ACTH-dependent causes

Critical Next Steps

1. Perform Confirmatory Testing 1, 2

Choose one of these tests to confirm autonomous aldosterone secretion:

• Intravenous saline suppression test (2L normal saline over 4 hours): Primary aldosteronism confirmed if aldosterone fails to suppress below 280 pmol/L (approximately 10 ng/dL) 3

• Oral salt loading test (300 mmol sodium/day for 3 days): Primary aldosteronism confirmed if aldosterone fails to suppress below 240 pmol/L 3

Important caveat: Some guidelines suggest confirmatory testing may be optional in cases with very high ARR (>1400 pmol/L/ng/mL/h) combined with aldosterone >440 pmol/L and spontaneous hypokalemia 3. However, the 2017 ACC/AHA guidelines still recommend confirmatory testing in most cases to avoid unnecessary adrenal venous sampling 1.

After Confirmation of Primary Aldosteronism

2. Refer to Endocrinology/Hypertension Specialist 1

The ACC/AHA guidelines give a Class I recommendation for specialist referral once screening is positive.

3. Obtain Adrenal CT Imaging 1, 2

• Use 3mm contiguous cuts to identify adenomas
• Rules out adrenal carcinoma (look for irregular morphology, lipid-poor lesions, size >3-5 cm) 2
• Helps guide decision about adrenal venous sampling

4. Proceed to Adrenal Venous Sampling (AVS) 1, 4, 2

AVS is essential to distinguish unilateral from bilateral disease and determine surgical candidacy:

• Unilateral disease (aldosterone-producing adenoma): Laparoscopic adrenalectomy cures hypokalemia in 100% and cures/improves hypertension in 90-100% of cases 1, 4

• Bilateral disease (idiopathic hyperaldosteronism): Medical management with mineralocorticoid receptor antagonists 1

Exception: AVS may be omitted in patients <40 years old with a solitary adenoma >1cm on CT and normal contralateral gland, as bilateral hyperplasia is rare in this population 4, 2

Medical Management Considerations

5. Initiate Mineralocorticoid Receptor Antagonist Therapy 1, 4, 5

While awaiting definitive workup or if surgery is declined/contraindicated:

• Spironolactone is first-line (lower cost, greater availability) 5
• Eplerenone is an alternative with fewer androgen-related side effects (gynecomastia, impotence in men; menstrual irregularities in women) 4
• Titrate to normalize blood pressure, correct hypokalemia, and increase renin from baseline 5, 6

Critical point: Untreated primary aldosteronism causes myocardial fibrosis, left ventricular hypertrophy, increased cardiovascular mortality, and progressive renal damage—even when blood pressure and potassium are controlled with other agents 4. This makes PA-specific therapy essential.

Address the Hyponatremia

The sodium of 101 mEq/L is severely low and requires immediate attention separate from the PA workup:

• Primary aldosteronism typically causes sodium retention, not hyponatremia 1
• This suggests a concurrent process (SIADH, hypothyroidism, medication effect, or rarely isolated aldosterone deficiency—though your aldosterone is elevated, ruling this out) 7
• Correct the hyponatremia cautiously (avoid overly rapid correction to prevent osmotic demyelination)
• Reassess electrolytes after correction, as severe hyponatremia can interfere with accurate interpretation of aldosterone testing

Common Pitfalls to Avoid

1. Do not delay confirmatory testing: A positive screening test alone is insufficient for diagnosis 1, 8

2. Do not rely on CT alone for lateralization: CT imaging misidentifies laterality in 21-25% of cases 4

3. Withdraw interfering medications before testing: Stop spironolactone for 6 weeks and eplerenone for 4 weeks before confirmatory testing and AVS 1, 4

4. Ensure potassium is normalized before testing: Hypokalemia can suppress aldosterone secretion and cause false-negative results 1

5. Do not treat with standard antihypertensives alone: PA requires specific mineralocorticoid receptor blockade to prevent cardiovascular complications 4